The ten top-performing funds of 2012 (so far)

TOP PERFORMERS

clock

Funds from Axa Framlington and Neptune top the best fund performer chart for 2012 so far, figures show.

The funds were collated by Hargreaves Lansdown using Lipper data. Top performing funds YTD 2012 Name, (IMA sector), % Growth AXA Framlington Biotech R Acc, (Specialist), 20.96 Neptune UK Mid Cap A Acc GBP UK, (All Companies), 19.66 Baillie Gifford British Smaller Companies A Acc, (UK Smaller Companies), 18.53 CF Odey UK Absolute Return GBP R Acc, (Absolute Return), 17.29 First State Asian Property Securities A GBP Acc, (Property), 16.65 JPM Europe Convergence Equity A Dis EUR, (Specialist), 15.37 MFS Meridian Funds European Smaller Cos A1 EUR, (European Smaller Compani...

To continue reading this article...

Join Professional Adviser for free

  • Unlimited access to real-time news, industry insights and market intelligence
  • Stay ahead of the curve with spotlights on emerging trends and technologies
  • Receive breaking news stories straight to your inbox in the daily newsletters
  • Make smart business decisions with the latest developments in regulation, investing retirement and protection
  • Members-only access to the editor’s weekly Friday commentary
  • Be the first to hear about our events and awards programmes

Join

 

Already a Professional Adviser member?

Login

More on Economics / Markets

'Discussion-worthy stuff': Chinese assets under pressure

'Discussion-worthy stuff': Chinese assets under pressure

China has an 18% share of global GDP and only a 3% MSCI ACWI weighting

Chris Justham
clock 02 April 2024 • 2 min read
Why investors 'can't outrun' slow-moving demographics

Why investors 'can't outrun' slow-moving demographics

'Demographic change is a key megatrend'

Darius McDermott
clock 07 March 2024 • 5 min read
Spring Budget 24: Ten key takeaways from Jeremy Hunt's speech

Spring Budget 24: Ten key takeaways from Jeremy Hunt's speech

British ISA, Office for Budget Responsibility, tax cuts

Valeria Martinez
clock 07 March 2024 • 4 min read